Stocks and Investing
by (remove) : Jessica Fye
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Jessica Fye
RSSJSONXMLCSV
Mon, September 16, 2024
Thu, September 5, 2024
Wed, September 4, 2024
Mon, August 26, 2024
Wed, August 21, 2024
Tue, August 20, 2024
Thu, August 15, 2024
Mon, August 5, 2024
Thu, July 25, 2024
Mon, July 15, 2024
Wed, July 3, 2024
Wed, June 12, 2024
Tue, May 21, 2024
Fri, May 3, 2024
Tue, April 2, 2024
Tue, March 26, 2024
Fri, March 22, 2024
Tue, March 19, 2024
Tue, February 6, 2024
Thu, February 1, 2024
Fri, December 1, 2023
Mon, November 20, 2023
Tue, May 2, 2023
Tue, April 25, 2023
Mon, April 10, 2023
Wed, February 8, 2023
Tue, December 6, 2022

Jessica Fye Upgraded (BNTX) to Hold and Increased Target to $125 on, Sep 16th, 2024


Published on 2024-10-28 14:15:38 - WOPRAI, Jessica Fye
  Print publication without navigation


Jessica Fye of JP Morgan, Upgraded "BioNTech SE" (BNTX) to Hold and Increased Target from $91 to $125 on, Sep 16th, 2024.

Jessica has made no other calls on BNTX in the last 4 months.



There are 3 other peers that have a rating on BNTX. Out of the 3 peers that are also analyzing BNTX, 2 agree with Jessica's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Akash Tewari of "Jefferies" Maintained at Hold with Increased Target to $96 on, Friday, September 13th, 2024
  • Yaron Werber of "TD Cowen" Maintained at Hold with Decreased Target to $85 on, Tuesday, August 6th, 2024


This is the rating of the analyst that currently disagrees with Jessica


  • Emmanuel Papadakis of "Deutsche Bank" Upgraded from Hold to Strong Buy and Held Target at $95 on, Wednesday, August 7th, 2024
Contributing Sources